Blog
Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Lag Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.63 per share a year ago
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.69 per share a year ago
DXC Technology Company. (DXC) Q4 Earnings and Revenues Beat Estimates
DXC Technology Company. (DXC) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.97 per share a year ago
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates
Codexis (CDXS) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.16 per share a year ago. These figures are
GCT Semiconductor Holding, Inc. (GCTS) Reports Q1 Loss, Misses Revenue Estimates
GCT Semiconductor Holding, Inc. (GCTS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.41 per share a year ago
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.17 per share a year ago. These
Compared to Estimates, Jack In The Box (JACK) Q2 Earnings: A Look at Key Metrics
For the quarter ended March 2025, Jack In The Box (JACK) reported revenue of $336.7 million, down 7.8% over the same period last year. EPS came in at $1.20, compared to $1.46 in the year-ago
Here's What Key Metrics Tell Us About Cisco (CSCO) Q3 Earnings
For the quarter ended April 2025, Cisco Systems (CSCO) reported revenue of $14.15 billion, up 11.4% over the same period last year. EPS came in at $0.96, compared to $0.88 in the year-ago quarter.
Boot Barn (BOOT) Q4 Earnings and Revenues Lag Estimates
Boot Barn (BOOT) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.01 per share a year ago. These figures
Nextracker (NXT) Surpasses Q4 Earnings and Revenue Estimates
Nextracker (NXT) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.96 per share a year ago. These figures
Aeva Technologies, Inc. (AEVA) Reports Q1 Loss, Tops Revenue Estimates
Aeva Technologies, Inc. (AEVA) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.56 per share a year ago. These
Cisco Systems (CSCO) Surpasses Q3 Earnings and Revenue Estimates
Cisco Systems (CSCO) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.88 per share a year ago. These
Jack In The Box (JACK) Q2 Earnings Surpass Estimates
Jack In The Box (JACK) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.46 per share a year ago. These
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates
ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.36 per share a year ago. These
Usio Inc (USIO) Reports Q1 Loss, Misses Revenue Estimates
Usio Inc (USIO) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.04. This compares to loss of $0.01 per share a year ago. These figures are adjusted for
Xos, Inc. (XOS) Reports Q1 Loss, Misses Revenue Estimates
Xos, Inc. (XOS) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $1.09. This compares to loss of $1.80 per share a year ago. These figures are
The Beachbody Company, Inc. (BODI) Reports Q1 Loss, Tops Revenue Estimates
The Beachbody Company, Inc. (BODI) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.33. This compares to loss of $1.92 per share a year ago
MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates
MDxHealth SA (MDXH) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.31 per share a year ago. These figures are
Ibotta (IBTA) Surpasses Q1 Earnings and Revenue Estimates
Ibotta (IBTA) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.54 per share a year ago. These figures are
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
Journey Medical Corporation (DERM) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.53 per share a year ago
Here's Why You Should Stick With Gold ETFs
Gold remains a vital part of an investor’s portfolio, driven by growing diversification needs and tariff-driven uncertainty. Central banks’ increasing purchases of the precious metal have also
Defense ETF (ITA) Hits New 52-Week High
For investors seeking momentum, iShares U.S. Aerospace & Defense ETF ITA is probably on the radar. The fund just hit a 52-week high and is up 29.63% from its 52-week low price of $129.14/share.
But
Is Raymond James' Outperform Rating on SMCI Stock a Buy Today?
Super Micro Computer, Inc. SMCI stock encountered controversies over the past year, including accounting violations and a non-compliance letter from Nasdaq. Although Supermicro avoided de-listing
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?
CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement
Are Options Traders Betting on a Big Move in Blue Owl Capital (OBDC) Stock?
Investors in Blue Owl Capital Corporation OBDC need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $5 Call had some of the highest


